Abstract:Background: A critical aspect of in silico drug discovery involves the prediction of drug-target affinity (DTA). Conducting wet lab experiments to determine affinity is both expensive and time-consuming, making it necessary to find alternative approaches. In recent years, deep learning has emerged as a promising technique for DTA prediction, leveraging the substantial computational power of modern computers. Methods: We proposed a novel sequence-based approach, named KC-DTA, for predicting drug-target affinity (DTA). In this approach, we converted the target sequence into two distinct matrices, while representing the molecule compound as a graph. The proposed method utilized k-mers analysis and Cartesian product calculation to capture the interactions and evolutionary information among various residues, enabling the creation of the two matrices for target sequence. For molecule, it was represented by constructing a molecular graph where atoms serve as nodes and chemical bonds serve as edges. Subsequently, the obtained target matrices and molecule graph were utilized as inputs for convolutional neural networks (CNNs) and graph neural networks (GNNs) to extract hidden features, which were further used for the prediction of binding affinity. Results: In order to evaluate the effectiveness of the proposed method, we conducted several experiments and made a comprehensive comparison with the state-of-the-art approaches using multiple evaluation metrics. The results of our experiments demonstrated that the KC-DTA method achieves high performance in predicting drug-target affinity (DTA). The findings of this research underscore the significance of the KC-DTA method as a valuable tool in the field of in silico drug discovery, offering promising opportunities for accelerating the drug development process. All the data and code are available for access on https://github.com/syc2017/KCDTA.

SubMDTA: drug target affinity prediction based on substructure extraction and multi-scale features

MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

Prediction of drug-target binding affinity based on multi-scale feature fusion

MFFDTA: A Multimodal Feature Fusion Framework for Drug-Target Affinity Prediction

Drug-target binding affinity prediction using message passing neural network and self supervised learning

Multimodal contrastive representation learning for drug-target binding affinity prediction

MTAF–DTA: multi-type attention fusion network for drug–target affinity prediction

GeneralizedDTA: combining pre-training and multi-task learning to predict drug-target binding affinity for unknown drug discovery

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

MMDTA: A Multimodal Deep Model for Drug-Target Affinity with a Hybrid Fusion Strategy

DataDTA: a multi-feature and dual-interaction aggregation framework for drug–target binding affinity prediction

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks

MFR-DTA: a multi-functional and robust model for predicting drug–target binding affinity and region

Breaking the barriers of data scarcity in drug–target affinity prediction

MFF-DTA: Multi-scale Feature Fusion for Drug-Target Affinity Prediction

Predicting Drug-Target Affinity by Learning Protein Knowledge From Biological Networks

MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction

SSR-DTA: Substructure-aware multi-layer graph neural networks for drug-target binding affinity prediction

MvGraphDTA: multi-view-based graph deep model for drug-target affinity prediction by introducing the graphs and line graphs

Drug-Target Binding Affinity Prediction by Combination Graph Neural Network and BiLSTM